search
Back to results

His Pacing Feasibility and Cardiac Electrical Activation

Primary Purpose

Pacing-Induced Cardiomyopathy, AV Block, Heart Failure

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
His Pacing
Sponsored by
Aalborg University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pacing-Induced Cardiomyopathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Permanent pacemaker indication with expected high demand of right ventricular pacing (>40%) and left ventricular ejection fraction >40%.

Exclusion Criteria:

  • No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines)
  • Hemodynamically unstable patients
  • Severely reduced kidney function
  • Former serious adverse reactions to contrast media
  • Pregnant or lactating
  • Severe psychiatric disorder which can compromise compliance with protocol

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    His Pacing

    Arm Description

    Implant of a supplementary His pacing lead in addition to a traditional RV pacing lead.

    Outcomes

    Primary Outcome Measures

    Rate of chronic His pacing success
    Chronic His capture with clinically acceptable pacing threshold (<=3.5V)

    Secondary Outcome Measures

    Rate of perioperative His pacing success
    Perioperative his capture with clinically acceptable pacing threshold (<=3.5V)
    QRS duration (ms)
    Comparing His pacing and RV pacing
    Changes in left ventricular echocardiographic two-dimensional strain dyssynchrony parameters
    Comparing left ventricular mechanical dyssynchrony during His pacing and RV pacing using echocardiographic two-dimensional longitudinal strain
    Changes in regional right and left ventricular electrical activation delay
    Comparing electrical activation pattern during His pacing and RV pacing using non-invasive electroanatomical mapping. This is achieved using software that merges data from a 12-lead electrocardiogram (ECG), chest wall three-dimensional picture of ECG lead positions, and a cardiac computed tomography scan.

    Full Information

    First Posted
    January 19, 2021
    Last Updated
    February 1, 2021
    Sponsor
    Aalborg University Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04739553
    Brief Title
    His Pacing Feasibility and Cardiac Electrical Activation
    Official Title
    His Pacing in Patients Without Need for Cardiac Resynchronization - Clinical Feasibility and Cardiac Electrical Activation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    February 15, 2021 (Anticipated)
    Primary Completion Date
    January 2024 (Anticipated)
    Study Completion Date
    January 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Aalborg University Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study will examine the clinical feasibility of His pacing in patients with expected high demand for ventricular pacing and no established indication for cardiac resynchronization therapy. Secondarily, examine differences in electrical and mechanical cardiac activation between traditional pacing and His pacing.
    Detailed Description
    After being informed about the study and potential risks, all eligible patients giving written consent will be included. The study is a clinical single-center interventional study. The patients (n = 25) need to have an expected high demand for ventricular pacing and no established class I indication for cardiac resynchronization therapy. They will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port. Postoperatively, the baseline examinations will include: transthoracic echocardiography, 12-lead ECG with a 3D photography of the chest wall to document ECG electrode location, and a contrast-enhanced cardiac CT scan. The echocardiography and ECG will be performed during traditional right ventricular pacing only and His pacing only. His pacing will be used as the permanent programming of choice if feasible during follow up. The CT scan is used for documenting the final positions of the pacing leads and to create a patient-specific 3D model of the cardiac electrical activation using a software which enables merging of a CT scan and ECG and a CT chest photography. During follow up (1-3 and 12 months), transthoracic echocardiography, 12-lead ECG and 3D chest photography are repeated for assessment of mechanical and electrical function during pacing. The performance of all implanted pacing lead will be evaluated at each follow up visit.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pacing-Induced Cardiomyopathy, AV Block, Heart Failure

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    25 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    His Pacing
    Arm Type
    Experimental
    Arm Description
    Implant of a supplementary His pacing lead in addition to a traditional RV pacing lead.
    Intervention Type
    Device
    Intervention Name(s)
    His Pacing
    Intervention Description
    The patients will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port.
    Primary Outcome Measure Information:
    Title
    Rate of chronic His pacing success
    Description
    Chronic His capture with clinically acceptable pacing threshold (<=3.5V)
    Time Frame
    Evaluated at 1 year follow up
    Secondary Outcome Measure Information:
    Title
    Rate of perioperative His pacing success
    Description
    Perioperative his capture with clinically acceptable pacing threshold (<=3.5V)
    Time Frame
    The implant procedure duration i.e. incision to skin closure
    Title
    QRS duration (ms)
    Description
    Comparing His pacing and RV pacing
    Time Frame
    Implantation to 1 year follow up
    Title
    Changes in left ventricular echocardiographic two-dimensional strain dyssynchrony parameters
    Description
    Comparing left ventricular mechanical dyssynchrony during His pacing and RV pacing using echocardiographic two-dimensional longitudinal strain
    Time Frame
    Implant to 1 year follow up
    Title
    Changes in regional right and left ventricular electrical activation delay
    Description
    Comparing electrical activation pattern during His pacing and RV pacing using non-invasive electroanatomical mapping. This is achieved using software that merges data from a 12-lead electrocardiogram (ECG), chest wall three-dimensional picture of ECG lead positions, and a cardiac computed tomography scan.
    Time Frame
    Implant to 1 year follow up

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Permanent pacemaker indication with expected high demand of right ventricular pacing (>40%) and left ventricular ejection fraction >40%. Exclusion Criteria: No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines) Hemodynamically unstable patients Severely reduced kidney function Former serious adverse reactions to contrast media Pregnant or lactating Severe psychiatric disorder which can compromise compliance with protocol
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Anna M Thøgersen, MD DMSc
    Phone
    +4597664427
    Email
    anmat@rn.dk
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jacob M Larsen, MD PhD
    Phone
    +4597664456
    Email
    jaml@rn.dk
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sam Riahi, MD PhD
    Organizational Affiliation
    Aalborg University Hospital
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Peter Søgaard, MD DMSc
    Organizational Affiliation
    Aalborg University Hospital
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    His Pacing Feasibility and Cardiac Electrical Activation

    We'll reach out to this number within 24 hrs